Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
ID: 357741Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $75K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357741

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-25-011.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), has announced a Limited Competition Small Grant Program aimed at supporting current and recently completed K01, K08, K23, and K25 award recipients. This funding opportunity, designated as RFA-HL-25-011, allows eligible applicants to secure up to $75,000 per year for projects lasting up to two years, with the goal of generating preliminary data for subsequent R01-equivalent applications. The program is particularly focused on advancing early-stage investigators towards independent research careers, emphasizing the inclusion of underrepresented groups in biomedical research. Interested applicants must adhere to strict submission guidelines via Grants.gov, with a close date for applications set for January 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-HL-25-011-Full-Announcement.html
    RFA-HL-25-011.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Heart, Lung, and Blood Institute (NHLBI), announces a Limited Competition Small Grant Program aimed at supporting current and recently completed K01, K08, K23, and K25 award recipients. This funding opportunity, titled RFA-HL-25-011, enables applicants to secure up to $75,000 per year for projects lasting up to two years, designed to generate preliminary data for subsequent R01-equivalent applications. The program emphasizes the advancement of early-stage investigators towards independent research careers, particularly underrepresented groups. In FY2024, up to 20 awards will be made with a total commitment of $2.4 million. Eligibility is restricted to specific K award recipients, and all applications must adhere strictly to submission guidelines via Grants.gov. Key aspects include a detailed application format, letters of support from mentors, and compliance with data management requirements. The initiative underscores the NIH's commitment to training and sustaining a diverse workforce in biomedical research, promoting innovative studies, and enhancing research independence for awardees.
    Similar Opportunities
    Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition Small Grant Program (R03) aimed at supporting current or recently completed NHLBI K01, K08, K23, and K25 awardees in enhancing their research capabilities as they transition to independent investigator roles. This funding opportunity allows eligible applicants to receive up to $75,000 per year for short-term research projects that can be completed within two years, focusing on activities such as pilot studies, proof of concept evaluations, and methodological development that generate preliminary data for future R01 applications. The program emphasizes the importance of fostering a diverse scientific workforce and is open for applications from January 13, 2023, with a closing date of January 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition Small Grant Program aimed at recipients of specific NIDDK career development awards (K01, K08, K23, K25) to support their research during the latter years of their awards. This program is designed to enhance the transition to independent research by allowing these recipients to conduct pilot studies, secondary analyses, and other small projects, which are crucial for generating publications and data necessary for future R01 applications. The grant provides direct costs of up to $75,000 per year for a maximum of two years, with applications required to include a Plan for Enhancing Diverse Perspectives (PEDP) as part of the review process. Interested applicants should note that the submission period opens on January 16, 2025, with subsequent deadlines through January 2028, and can direct inquiries to grantsinfo@nih.gov for further information.
    Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has announced a Limited Competition Small Grant Program aimed at supporting current K01, K08, K23, and K25 award recipients. This program is designed to facilitate the transition of these early-career researchers to fully independent investigator status by providing funding for small, self-contained research projects, with grants offering up to $75,000 in direct costs per year for a maximum project period of two years. The initiative encourages applicants to demonstrate their growing independence and ability to secure future funding, particularly for R01 applications, while adhering to NIH policies regarding human subjects and clinical trials. Interested applicants must submit their proposals by September 7, 2025, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition Small Grant Program aimed at recipients of NIAMS K01, K08, K23, and K25 awards, providing funding opportunities to enhance their research capabilities. This program allows eligible applicants to apply for Small Grant (R03) funding, which offers up to $100,000 for a two-year period to support pilot studies, secondary data analyses, and small-scale research projects, specifically excluding clinical trials. The initiative is designed to facilitate the transition of early-career scientists to independent investigator status, ultimately encouraging them to pursue R01 grants. Interested applicants must adhere to specific application guidelines, with submission dates beginning January 19, 2025, and a complete application deadline of February 20, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition Small Grant Program (R03) aimed at supporting recipients of K01, K08, K23, and K25 awards from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This program allows eligible awardees, specifically those in their second to fourth award year who do not yet hold independent R01 grants, to request up to $100,000 in direct costs over a two-year period to enhance their research capabilities, focusing on pilot studies, methodology development, and secondary data analysis, while explicitly excluding clinical trials. The initiative is designed to foster the development of early-career scientists and strengthen the research landscape by generating additional publications and data necessary for future R01 grant applications. Interested applicants must submit their proposals by February 19, 2025, and can find more information and application guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 recipients, aimed at supporting those who have completed the first two years of their award. This program, identified as PAR-25-176, seeks to enhance the research capabilities of SERCA K01 awardees as they transition to independent investigator status, focusing on projects such as pilot studies, feasibility studies, and methodology development, while explicitly excluding clinical trial applications. Each project may receive up to $75,000 in direct costs over a two-year period, with applications encouraged from a diverse range of eligible organizations, including higher education institutions and community-based organizations. Interested applicants should note that the application deadline is May 7, 2026, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NHLBI Career Transition Award (K22), a federal grant aimed at supporting postdoctoral fellows and doctoral-level researchers transitioning from intramural NIH research to independent extramural research. This program features a two-phase support structure: an up to two-year mentored intramural phase followed by a three-year extramural phase, contingent upon a successful review of the awardee's research progress. The grant is designed to cultivate future researchers capable of addressing critical health-related questions and enhancing the scientific community, with an emphasis on diversity and inclusion of underrepresented groups. Interested applicants must have a relevant doctoral degree and adhere to stringent application instructions, with proposals due starting September 12, 2024. For further details, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and the opportunity is open until July 12, 2027.
    Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)." This initiative aims to support new investigators from diverse and underrepresented backgrounds in biomedical research, enabling them to conduct small-scale projects that align with the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and other participating institutes. The grants, with a maximum budget of $125,000 per year for a project period not exceeding three years, are intended to facilitate the transition of these researchers toward independence while addressing health disparities. Interested applicants must demonstrate that they have had less than $125,000 in direct costs from combined active research funding and can submit proposals starting in early 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-097.html.
    Limited Competition: Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Heart, Lung, and Blood Institute (NHLBI), has announced a Limited Competition Funding Opportunity titled "Physician Scientist Transition to Independence in Blood Science Research" (R00 - Clinical Trial Optional). This initiative aims to support the transition of outstanding blood science researchers with clinical doctorate degrees from mentored research positions to independent faculty roles, providing up to three years of funding for innovative research in blood science. The program is particularly focused on enhancing the scientific workforce by promoting diversity and fostering independent research careers that address critical health challenges in hematology. Interested applicants must submit their proposals by March 28, 2025, with a total funding ceiling of $250,000 available for new awards, and can direct inquiries to grantsinfo@nih.gov for further information.
    Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition Small Grant Program aimed at supporting recipients of the Special Emphasis Research Career Award (SERCA) K01 who have completed the first two years of their award. This program provides funding of up to $75,000 in direct costs over a maximum period of two years to facilitate small-scale research projects, excluding clinical trials, thereby assisting awardees in transitioning to independent research roles. The initiative is part of NIH's commitment to enhancing the diversity of research talent and advancing biomedical research, particularly in veterinary science. Interested applicants from eligible organizations must adhere to submission guidelines, with applications accepted until May 7, 2026; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-127.html.